MRSN logo
MRSN

Mersana Therapeutics Inc

Biotechnology

Mersana Therapeutics Inc (MRSN) Earnings

Last reported
May 13, 2026
EPS estimate
-$3.41
EPS actual
Revenue est.
$2.7M
Revenue actual